DOW JONES22,303.50+666.72 3.08%
S&P 5002,622.18+80.71 3.18%
NASDAQ7,774.15+271.77 3.62%

Raymond James Maintains Strong Buy on Antares Pharma, Raises Price Target to $6

Raymond James maintains Antares Pharma (NASDAQ:ATRS) with a Strong Buy and raises the price target from $5.65 to $6.

Benzinga · 03/04/2020 12:22

Raymond James maintains Antares Pharma (NASDAQ:ATRS) with a Strong Buy and raises the price target from $5.65 to $6.